Metabolomics in the Diagnosis of Systemic Autoimmune Diseases: A MiniReview with a Focus on Psoriatic Arthritis and Rheumatoid Arthritis

Abstract

Complex and overlapping clinical presentation of systemic autoimmune diseases, such as Psoriatic arthritis (PsA) and Rheumatoid arthritis (RA), creates significant difficulties in early diagnosis and management. Metabolomics, as a rapidly developing field, holds a great potential to identify the intricate metabolic disturbances related to these conditions. This may assist in the early and accurate diagnosis, and personally-tailored treatment of these conditions.